 TOP STORIES YOU MISSED |
Featured Stories |
| |
  | FCC DISTRIBUTES $100M TO ENHANCE TELEHEALTH SERVICES AMID PANDEMIC The Federal Communications Commission (FCC) allocated nearly $105 million in funding to over 300 healthcare providers to boost telehealth infrastructure as coronavirus outbreaks continue, per Fierce Healthcare. We think that in order for telehealth to take off in underserved areas, more funding will need to be allocated to smaller, rural hospitals — rather than larger, well-funded health systems — to build up their telehealth platforms. As virtual care flourishes for larger telehealth vendors and health systems, we expect telehealth adoption to remain high post-pandemic — and we think its ability to offer better doc-patient engagement will be a driving factor in sustaining uptake. Telehealth use continues to skyrocket amid the pandemic, and we don’t expect adoption rates to fall back down to pre-coronavirus levels once outbreaks subside. We think this will be driven in part by the fact that patients will get accustomed to the convenience telehealth affords, and they won’t want to trade that in post-pandemic. |
|---|
|
| |
  | MODERNA’S CORONAVIRUS VACCINE TO START FINAL STAGE TRIAL NEXT MONTH Biotech Moderna revealed that it’s on pace to start final stage human trials of its coronavirus vaccine candidate by July, according to Bloomberg. The final stage of the biotech’s coronavirus vaccine human trials will be conducted in partnership with the US National Institute of Allergy and Infectious Diseases, and will see 30,000 participants receive the vaccine candidate to prove it prevents individuals from contracting the virus. Entering the final stage of the human trial process represents significant progress for Moderna’s coronavirus vaccine candidate — but earning final approval to roll out the vaccine to the US masses will be paramount in measuring biotechs’ potential to rapidly bring drugs to market, considering only 14% of all drugs in clinical trials eventually secure FDA approval. |
|---|
|
  | MONTEFIORE USES PREDICTIVE AI TO REDUCE PREVENTABLE ER VISITS New York-based Montefiore Medical Center indicated that the hospital was able to reduce the number of preventable ER visits at its facility by utilizing a predictive analytics tool to provide personalized levels of care, per Healthcare IT News. Predictive analytics was gaining traction among US health systems pre-pandemic and was on track to reach near full penetration by the end of the year — but we expect to see a significant slowdown in uptake through 2020 given the pandemic-induced financial strain plaguing hospitals across the US. We expect 80% of US health systems will be utilizing predictive analytics by the end of the year, and think US hospitals’ investments in the tech will grow once their financial situation has improved, given its ability to reduce the number of preventable ER visits: Unnecessary ER visits cost the US healthcare system $32 billion each year. |
|---|
|
 |
Like What You're Reading?
Stay on top and subscribe to the Digital Health Briefing for $695 to receive:
|
